Novel mechanism-based treatments for pediatric anxiety and depressive disorders

被引:2
|
作者
Sylvester, Chad M. [1 ,2 ]
Luby, Joan L. [1 ]
Pine, Daniel S. [3 ]
机构
[1] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA
[2] Washington Univ, Dept Radiol, St Louis, MO 63110 USA
[3] NIMH, Emot & Dev Branch, St Louis, MO USA
关键词
ATTENTION BIAS MODIFICATION; COGNITIVE-BEHAVIORAL THERAPY; TRANSCRANIAL MAGNETIC STIMULATION; INTRINSIC FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX ACTIVATION; CLINICAL-PRACTICE GUIDELINE; CHILD INTERACTION THERAPY; DSM-IV DISORDERS; COMPARATIVE EFFICACY; ADOLESCENT ANXIETY;
D O I
10.1038/s41386-023-01709-x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pediatric anxiety and depressive disorders are common, can be highly impairing, and can persist despite the best available treatments. Here, we review research into novel treatments for childhood anxiety and depressive disorders designed to target underlying cognitive, emotional, and neural circuit mechanisms. We highlight three novel treatments lying along a continuum relating to clinical impact of the disorder and the intensity of clinical management required. We review cognitive training, which involves the lowest risk and may be applicable for problems with mild to moderate impact; psychotherapy, which includes a higher level of clinical involvement and may be sufficient for problems with moderate impact; and brain stimulation, which has the highest potential risks and is therefore most appropriate for problems with high impact. For each treatment, we review the specific underlying cognitive, emotional, and brain circuit mechanisms that are being targeted, whether treatments modify those underlying mechanisms, and efficacy in reducing symptoms. We conclude by highlighting future directions, including the importance of work that leverages developmental windows of high brain plasticity to time interventions to the specific epochs in childhood that have the largest and most enduring life-long impact.
引用
收藏
页码:262 / 275
页数:14
相关论文
共 50 条
  • [1] Novel mechanism-based treatments for pediatric anxiety and depressive disorders
    Chad M. Sylvester
    Joan L. Luby
    Daniel S. Pine
    Neuropsychopharmacology, 2024, 49 : 262 - 275
  • [2] Mechanism-Based Treatments in Neurodevelopmental Disorders: Fragile X Syndrome
    Berry-Kravis, Elizabeth
    PEDIATRIC NEUROLOGY, 2014, 50 (04) : 297 - 302
  • [3] Perfectionism in Pediatric Anxiety and Depressive Disorders
    Affrunti, Nicholas W.
    Woodruff-Borden, Janet
    CLINICAL CHILD AND FAMILY PSYCHOLOGY REVIEW, 2014, 17 (03) : 299 - 317
  • [4] Perfectionism in Pediatric Anxiety and Depressive Disorders
    Nicholas W. Affrunti
    Janet Woodruff-Borden
    Clinical Child and Family Psychology Review, 2014, 17 : 299 - 317
  • [5] Novel Mechanism-Based Treatments for Disruptive Mood Dysregulation Disorder
    Brotman, Melissa
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S43 - S43
  • [6] Emerging Domain-Based Treatments for Pediatric Anxiety Disorders
    Lazarov, Amit
    Bar-Haim, Yair
    BIOLOGICAL PSYCHIATRY, 2021, 89 (07) : 716 - 725
  • [7] Evidence-Based Psychosocial Treatments for Pediatric Mood and Anxiety Disorders
    MacPherson H.A.
    Fristad M.A.
    Current Treatment Options in Psychiatry, 2014, 1 (1) : 48 - 65
  • [8] Women, Anxiety, and Menopause: Novel Treatments for Anxiety Disorders
    Novick, Andrew M.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (12): : 1451 - 1451
  • [9] Towards Mechanism-Based Treatments for Fragile X Syndrome
    Kumari, Daman
    Gazy, Inbal
    BRAIN SCIENCES, 2019, 9 (08)
  • [10] Objective sleep in pediatric anxiety disorders and major depressive disorder
    Forbes, Erika E.
    Bertocci, Michele A.
    Gregory, Alice M.
    Ryan, Neal D.
    Axelson, David A.
    Birmaher, Boris
    Dahl, Ronald E.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2008, 47 (02): : 148 - 155